- Media
June 17, 2013
Roche's Avastin approved in Japan for treatment of the most aggressive form of brain cancer
Roche today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Avastin (bevacizumab) for the treatment of malignant glioma, including newly diagnosed glioblastoma (GBM) in combination with radiotherapy and temozolomide chemotherapy, and as monotherapy for treatment of recurrent GBM and certain other types of high grade glioma following prior therapy. more
Media: News and Press Releases
- June 17, 2013
Roche's Avastin approved in Japan for treatment of the most aggressive form of brain cancer - June 14, 2013
10th anniversary of Roche Children's Walk unites Roche employees worldwide in support for vulnerable children in Malawi and the world - June 13, 2013
Roche's RoACTEMRA shows long-term efficacy in monotherapy and also benefits in early rheumatoid arthritis
- June 12, 2013
Roche at ASCO13 (American Society of Clinical Oncology) - June 06, 2013
New Roche purpose statement: Doing now what patients need next - June 04, 2013
Drawn to Science: Genes and stripes
Featured Links
Statements
June 05 2013
Frequently Asked Questions on the Roche data transparency policy
October 26, 2012
Roche statement on EMA procedure related to alleged infringement of pharmacovigilance obligations
Services
- Media Contacts
- Media Archive
- Medialibrary
- Corporate Publications
- RSS-Feeds
- Roche Events Podcast
- Subscribe to Roche News
-
Basel, Switzerland, July 25, 2013
Half Year Results 2013 -
Basel, Switzerland, October 17, 2013
Third quarter sales